Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 430 participants.
Also called NCT02360423
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 430 participants
- Sponsor
- CID S.p.A.
- Registry
-
NCT02360423
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02360423. Randomized; no masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2016-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions
- Condition
- Coronary Artery Disease
- Intervention (Device)
- CRE8 sirolimus-eluting stent
- Intervention (Device)
- RESOLUTE zotarolimus-eluting stent
- Lead sponsor
- CID S.p.A.
Record details
- Record id
cardio:ct-nct02360423- Content hash
40dbaca1a90f6cb4d8def03706ca5e614f52a136207e2f8c9280b5c8b9976ddf